{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:14:26Z","timestamp":1792134866919,"version":"4.4.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T00:00:00Z","timestamp":1711756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100007210","name":"Varian Medical Systems","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007210","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Our purpose was to determine the utility of [68Ga]-DOTATATE PET\/MRI in meningioma response assessment following radiosurgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with meningioma prospectively underwent postoperative DOTATATE PET\/MRI. Co-registered PET and gadolinium-enhanced T1-weighted MRI were employed for radiosurgery planning. Follow-up DOTATATE PET\/MRI was performed at 6\u201312 months post-radiosurgery. Maximum absolute standardized uptake value (SUV) and SUV ratio (SUVRSSS) referencing superior sagittal sinus (SSS) blood pool were obtained. Size change was determined by Response Assessment in Neuro-Oncology (RANO) criteria. Association of SUVRSSS change magnitude and progression-free survival (PFS) was evaluated using Cox regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-seven patients with 64 tumors (26% World Health Organization [WHO]-1, 41% WHO-2, 26% WHO-3, and 7% WHO-unknown) were prospectively followed post stereotactic radiosurgery (SRS) or stereotactic body radiotherapy (SBRT; mean dose: 30 Gy, modal dose 35 Gy, mean of 5 fractions). Post-irradiation SUV and SUVRSSS decreased by 37.4% and 44.4%, respectively (P\u2005&amp;lt;\u2005.0001). Size product decreased by 8.9%, thus failing to reach the 25% significance threshold as determined by RANO guidelines. Mean follow-up time was 26 months (range: 6\u201344). Overall mean PFS was 83% and 100%\/100%\/54% in WHO-1\/-2\/-3 subcohorts, respectively, at 34 months. At maximum follow-up (42\u201344 months), PFS was 100%\/83%\/54% in WHO-1\/-2\/-3 subcohorts, respectively. Cox regression analyses revealed a hazard ratio of 0.48 for 10-unit reduction in SUVRSSS in the SRS cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>DOTATATE PET SUV and SUVRSSS demonstrated marked, significant decrease post-radiosurgery. Lesion size decrease was statistically significant; however, it was not clinically significant by RANO criteria. DOTATATE PET\/MR thus represents a promising imaging biomarker for response assessment in meningiomas treated with radiosurgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>ClinicalTrials.gov Identifier<\/jats:title>\n                    <jats:p>NCT04081701<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuonc\/noae067","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T05:09:07Z","timestamp":1711775347000},"page":"1526-1535","source":"Crossref","is-referenced-by-count":32,"title":["[Ga68] DOTATATE PET\/MRI-guided radiosurgical treatment planning and response assessment in meningiomas"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6470-5400","authenticated-orcid":false,"given":"Jana","family":"Ivanidze","sequence":"first","affiliation":[{"name":"Department of Radiology, Weill Cornell Medicine , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Jung","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Weill Cornell Medicine , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsalan","family":"Haghdel","sequence":"additional","affiliation":[{"name":"Department of Radiology, Weill Cornell Medicine , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Tae","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Radiology, Weill Cornell Medicine , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arindam","family":"Roy Choudhury","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Population Health Sciences, Weill Cornell Medicine , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Population Health Sciences, Weill Cornell Medicine , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1166-6073","authenticated-orcid":false,"given":"Rohan","family":"Ramakrishna","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Weill Cornell Medicine , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore H","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Weill Cornell Medicine , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babacar","family":"Cisse","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Weill Cornell Medicine , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Stieg","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Weill Cornell Medicine , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leland","family":"Muller","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Weill Cornell Medicine , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R","family":"Osborne","sequence":"additional","affiliation":[{"name":"Department of Radiology, Weill Cornell Medicine , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv S","family":"Magge","sequence":"additional","affiliation":[{"name":"Brain Tumor Center, Weill Cornell Medicine , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas A","family":"Karakatsanis","sequence":"additional","affiliation":[{"name":"Department of Radiology, Weill Cornell Medicine , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Roytman","sequence":"additional","affiliation":[{"name":"Department of Radiology, Weill Cornell Medicine , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eaton","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Radiology, Weill Cornell Medicine , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan C","family":"Pannullo","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Weill Cornell Medicine , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3311-0129","authenticated-orcid":false,"given":"Joshua D","family":"Palmer","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Ohio State University , Columbus, Ohio , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P S","family":"Knisely","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Weill Cornell Medicine , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,30]]},"reference":[{"issue":"1","key":"2024080523450724200_CIT0001","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3171\/2016.11.JNS161170","article-title":"Intermediate-risk meningioma: Initial outcomes from NRG Oncology RTOG 0539","volume":"129","author":"Rogers","year":"2018","journal-title":"J Neurosurg."},{"issue":"July-Aug","key":"2024080523450724200_CIT0002","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.clinimag.2019.04.006","article-title":"Molecular imaging and therapy of somatostatin receptor positive tumors","volume":"56","author":"Ivanidze","year":"2019","journal-title":"Clin Imaging."},{"issue":"1","key":"2024080523450724200_CIT0003","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3171\/jns.1985.62.1.0018","article-title":"Meningioma: Analysis of recurrence and progression following neurosurgical resection","volume":"62","author":"Mirimanoff","year":"1985","journal-title":"J Neurosurg."},{"issue":"Jan","key":"2024080523450724200_CIT0004","doi-asserted-by":"crossref","first-page":"e588","DOI":"10.1016\/j.wneu.2017.10.028","article-title":"The relevance of simpson grade resections in modern neurosurgical treatment of world health organization grade I, II, and III Meningiomas","volume":"109","author":"Ehresman","year":"2018","journal-title":"World Neurosurg"},{"issue":"5","key":"2024080523450724200_CIT0005","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/jon.12632","article-title":"Gallium-68 DOTATATE PET in the evaluation of intracranial meningiomas","volume":"29","author":"Ivanidze","year":"2019","journal-title":"J Neuroimaging"},{"issue":"10","key":"2024080523450724200_CIT0006","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.2967\/jnumed.117.191932","article-title":"Improved detection of transosseous meningiomas using (68)Ga-DOTATATE PET\/CT compared with contrast-enhanced MRI","volume":"58","author":"Kunz","year":"2017","journal-title":"J Nucl Med."},{"issue":"1","key":"2024080523450724200_CIT0007","first-page":"vdab012","article-title":"[(68)Ga]-DOTATATE PET\/MRI as an adjunct imaging modality for radiation treatment planning of meningiomas","volume":"3","author":"Mahase","year":"2021","journal-title":"Neurooncol. Adv.."},{"issue":"2","key":"2024080523450724200_CIT0008","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00259-009-1270-2","article-title":"Potential impact of 68Ga-DOTATOC PET\/CT on stereotactic radiotherapy planning of meningiomas","volume":"37","author":"Nyuyki","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"1","key":"2024080523450724200_CIT0009","doi-asserted-by":"crossref","first-page":"9064","DOI":"10.1038\/s41598-021-87866-9","article-title":"Comparison of diagnostic value of 68 Ga-DOTATOC PET\/MRI and standalone MRI for the detection of intracranial meningiomas","volume":"11","author":"Einhellig","year":"2021","journal-title":"Sci Rep."},{"issue":"10","key":"2024080523450724200_CIT0010","first-page":"13185","article-title":"Expression of somatostatin receptors (SSTR1-SSTR5) in meningiomas and its clinicopathological significance","volume":"8","author":"Silva","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"9","key":"2024080523450724200_CIT0011","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00259-012-2155-3","article-title":"Detection of cranial meningiomas: comparison of (6)(8)Ga-DOTATOC PET\/CT and contrast-enhanced MRI","volume":"39","author":"Afshar-Oromieh","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"3","key":"2024080523450724200_CIT0012","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2967\/jnumed.114.149120","article-title":"Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue","volume":"56","author":"Rachinger","year":"2015","journal-title":"J Nucl Med."},{"issue":"5","key":"2024080523450724200_CIT0013","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/jon.12632","article-title":"Gallium-68 DOTATATE PET in the evaluation of intracranial meningiomas","volume":"29","author":"Ivanidze","year":"2019","journal-title":"J Neuroimaging."},{"issue":"4","key":"2024080523450724200_CIT0014","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2967\/jnumed.106.035667","article-title":"68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT","volume":"48","author":"Gabriel","year":"2007","journal-title":"J Nucl Med."},{"issue":"3","key":"2024080523450724200_CIT0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/brainsci11030375","article-title":"(68)Ga-DOTATOC PET\/CT follow up after single or hypofractionated gamma knife ICON radiosurgery for meningioma patients","volume":"11","author":"Barone","year":"2021","journal-title":"Brain Sci"},{"issue":"4","key":"2024080523450724200_CIT0016","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ijrobp.2019.11.028","article-title":"High-risk meningioma: Initial outcomes from NRG Oncology\/RTOG 0539","volume":"106","author":"Rogers","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"3","key":"2024080523450724200_CIT0017","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11060-021-03882-9","article-title":"The role of single-fraction stereotactic radiosurgery for atypical meningiomas (WHO grade II): Treatment results based on a 25-year experience","volume":"155","author":"Hasegawa","year":"2021","journal-title":"J Neurooncol."},{"issue":"2","key":"2024080523450724200_CIT0018","doi-asserted-by":"crossref","first-page":"e210067","DOI":"10.1148\/rycan.210067","article-title":"Dynamic (68)Ga-DOTATATE PET\/MRI in the diagnosis and management of intracranial meningiomas","volume":"4","author":"Ivanidze","year":"2022","journal-title":"Radiol Imaging Cancer"},{"issue":"1","key":"2024080523450724200_CIT0019","doi-asserted-by":"crossref","first-page":"9256","DOI":"10.1038\/s41598-022-13467-9","article-title":"Evaluating diagnostic accuracy and determining optimal diagnostic thresholds of different approaches to [68Ga]-DOTATATE PET\/MRI analysis in patients with meningioma","volume":"12","author":"Kim","year":"2022","journal-title":"Sci Rep."},{"issue":"1","key":"2024080523450724200_CIT0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/neuonc\/noy137","article-title":"Proposed response assessment and endpoints for meningioma clinical trials: Report from the response assessment in neuro-oncology working group","volume":"21","author":"Huang","year":"2019","journal-title":"Neuro Oncol"},{"issue":"Mar","key":"2024080523450724200_CIT0021","doi-asserted-by":"crossref","first-page":"e856","DOI":"10.1016\/j.wneu.2017.12.178","article-title":"Agreement between extent of meningioma resection based on surgical simpson grade and based on postoperative magnetic resonance imaging findings","volume":"111","author":"Slot","year":"2018","journal-title":"World Neurosurg"},{"issue":"Oct","key":"2024080523450724200_CIT0022","first-page":"1","article-title":"The","volume":"1","author":"Schwartz","year":"2020","journal-title":"J Neurosurg."},{"issue":"8","key":"2024080523450724200_CIT0023","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.3390\/cancers14082007","article-title":"The simpson grading: is it still valid","volume":"14","author":"Chotai","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2024080523450724200_CIT0024","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/neuros\/nyaa333","article-title":"Simpson grade revisited - intraoperative estimation of the extent of resection in meningiomas versus postoperative somatostatin receptor positron emission tomography\/computed tomography and magnetic resonance imaging","volume":"88","author":"Ueberschaer","year":"2020","journal-title":"Neurosurgery."},{"issue":"11","key":"2024080523450724200_CIT0025","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/neuonc\/noab150","article-title":"EANO guideline on the diagnosis and management of meningiomas","volume":"23","author":"Goldbrunner","year":"2021","journal-title":"Neuro Oncol"},{"issue":"Nov","key":"2024080523450724200_CIT0026","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1186\/s13063-015-1040-3","article-title":"The ROAM\/EORTC-1308 trial: Radiation versus observation following surgical resection of atypical meningioma: study protocol for a randomised controlled trial","volume":"16","author":"Jenkinson","year":"2015","journal-title":"Trials"},{"issue":"2","key":"2024080523450724200_CIT0027","first-page":"115","article-title":"Radiotherapy intensification for atypical and malignant meningiomas: A systematic review","volume":"11","author":"Gaito","year":"2023","journal-title":"Neurooncol. Pract.."},{"issue":"3","key":"2024080523450724200_CIT0028","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ijrobp.2023.09.026","article-title":"Dose-escalated radiation therapy is associated with improved outcomes for high-grade meningioma","volume":"118","author":"Zeng","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"2","key":"2024080523450724200_CIT0029","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11060-021-03934-0","article-title":"Stereotactic radiosurgery in the management of petroclival meningiomas: A systematic review and meta-analysis of treatment outcomes of primary and adjuvant radiosurgery","volume":"157","author":"Bin Alamer","year":"2022","journal-title":"J Neurooncol."},{"issue":"3","key":"2024080523450724200_CIT0030","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ijrobp.2021.01.048","article-title":"Treatment of WHO Grade 2 meningiomas with stereotactic radiosurgery: Identification of an optimal group for SRS using RPA","volume":"110","author":"Kowalchuk","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"5","key":"2024080523450724200_CIT0031","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/neuros\/nyaa553","article-title":"Stereotactic Radiosurgery for Atypical (World Health Organization II) and Anaplastic (World Health Organization III) Meningiomas: Results from a multicenter, international cohort study","volume":"88","author":"Shepard","year":"2021","journal-title":"Neurosurgery."},{"issue":"1","key":"2024080523450724200_CIT0032","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13014-021-01759-9","article-title":"Adjuvant radiotherapy versus observation following gross total resection for atypical meningioma: A systematic review and meta-analysis","volume":"16","author":"Chun","year":"2021","journal-title":"Radiat Oncol."},{"issue":"11","key":"2024080523450724200_CIT0033","first-page":"noad244","article-title":"Efficacy and toxicity of bimodal radiotherapy in WHO grade 2 meningiomas following subtotal resection with carbon ion boost: prospective phase 2 MARCIE trial","volume":"Dec","author":"Deng","year":"2023","journal-title":"Neuro Oncol"},{"issue":"3","key":"2024080523450724200_CIT0034","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2967\/jnumed.114.149120","article-title":"Increased 68Ga-DOTATATE Uptake in PET imaging discriminates meningioma and tumor-free tissue","volume":"56","author":"Rachinger","year":"2015","journal-title":"J Nucl Med."},{"issue":"1","key":"2024080523450724200_CIT0035","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13014-021-01875-6","article-title":"(68)Ga-DOTATATE PET-CT as a tool for radiation planning and evaluating treatment responses in the clinical management of meningiomas","volume":"16","author":"Kowalski","year":"2021","journal-title":"Radiat Oncol."},{"issue":"15","key":"2024080523450724200_CIT0036","first-page":"113","article-title":"(68)Ga-DOTATATE PET-based radiation contouring creates more precise radiation volumes for meningioma patients","volume":"Jul","author":"Perlow","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"1","key":"2024080523450724200_CIT0037","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijrobp.2005.12.006","article-title":"Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET","volume":"65","author":"Milker-Zabel","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"1","key":"2024080523450724200_CIT0038","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijrobp.2012.03.021","article-title":"Contribution of 68Ga-DOTATOC PET\/CT to target volume delineation of skull base meningiomas treated with stereotactic radiation therapy","volume":"85","author":"Graf","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"2","key":"2024080523450724200_CIT0039","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/neuonc\/nou131","article-title":"Comparison of (6)(8)Ga-DOTATOC-PET\/CT and PET\/MRI hybrid systems in patients with cranial meningioma: Initial results","volume":"17","author":"Afshar-Oromieh","year":"2015","journal-title":"Neuro Oncol"},{"issue":"Oct","key":"2024080523450724200_CIT0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.clinimag.2020.04.026","article-title":"Somatostatin receptor-2 negative meningioma: pathologic correlation and imaging implications","volume":"66","author":"Roytman","year":"2020","journal-title":"Clin Imaging."}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noae067\/57332340\/noae067.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/26\/8\/1526\/58739903\/noae067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/26\/8\/1526\/58739903\/noae067.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T19:47:30Z","timestamp":1722887250000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/26\/8\/1526\/7637829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,30]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,3,30]]},"published-print":{"date-parts":[[2024,8,5]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noae067","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,3,30]]}}}